Journal
EUROPEAN JOURNAL OF RADIOLOGY
Volume 83, Issue 6, Pages 919-929Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.ejrad.2014.02.010
Keywords
FDG PET-CT; Breast; Benign
Funding
- Cancer Center Support Grant from the National Institutes of Health [CA016672]
Ask authors/readers for more resources
F-18-fluorodeoxyglucose positron emission computed tomography (FDG PET-CT) is widely used in the initial staging and response evaluation of patients with malignancy. This review describes a spectrum of benign breast findings incidentally detected by FDG PET-CT at staging that may be misinterpreted as malignancy. We describe the pattern of distribution and intensity of FDG uptake in a spectrum of benign breast diseases with their corresponding typical morphological imaging characteristics to help the nuclear medicine physician and/or general radiologist identify benign lesions, avoiding unnecessary breast imaging work-up and biopsies. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available